
February 2017 Vol 10, No 1
Joseph Lee, PhD, Ryan Pelkey, MS, Julieanna Gubitosa, BS, Michael F. Henrick, MBA, Michael L. Ganz, PhD
Identifying the Most Clinically and Economically Effective Therapies for Rheumatoid Arthritis Remains a Challenge for Providers and Payers
Understanding Patients’ Demographics Is Key to Improving Clinical and Economic Healthcare Outcomes
Rheumatoid Arthritis, Biologic Drugs, and Associated Cost
Results 1 - 6 of 6